Praxis Bioresearch is an NIH Innovation Zone Company developing a novel treatment for behavioral problems in Alzheimer's Disease. It's core team consists of scientific and business leaders in CNS drug development with a proven track record in large pharma. Its lead asset, PRX-P4-003 is a novel clinical stage prodrug with protected intellectual propeerty and a validated mechanism.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):